Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by prophetoffactzon Feb 22, 2024 12:39pm
44 Views
Post# 35893581

RE:RE:RE:RE:RE:RE:RE:RE:Let's be more balanced and positive

RE:RE:RE:RE:RE:RE:RE:RE:Let's be more balanced and positive

Tencents wrote: Yes they have indicated to avance on some production capabilities 
but revenue generation in the ceo s opinion is a bunch of years down the road -which makes since as going from pilot to delivering products is not an easy task 


At 28:50 Gilles says they are "very, very close" to launching powder oat beta glucan. Symrise will resolubilize in Germany. It won't be years away.

Ceapro (TSX.V: CZO) CEO Gilles Gagnon – Small Cap Discoveries

At 24:40 of the presentation from October Gilles says "...this 100L vessel - that will be a small commercial scale - will allow us to start marketing yeast beta glucan as an immune booster." The facility is expected to be completed in Q3 2024.

Natex's facility where PGX is being scaled to 100L may be a toll facility that allows small-scale commercial production as its website says: "Services: Test and toll extraction of limited quantities for marketing purposes. Our facilities can be used at a daily rate."

The 50L facility, which is expected to be commissioned at any time, will allow the production of material for a clinical study according to the October presentation. . 

Previously CZO said it would work with partners for formulation and testing so the 50L facility could be a catalyst for a PGX deal. This could be in a similar timeframe as an AEZS diagnostic deal. Perhaps capital from the AEZS deal allows CZO to enter a stronger deal: 

"This next phase of scale up will allow us to work with commercial partners in nutraceuticals and pharmaceuticals to formulate, test, and commercialize novel products and formulations, including novel functional foods and beverages, novel drugs and various forms of delivery systems,” said Gilles Gagnon, M.Sc., MBA, President and CEO." news release


Show the specific reference where in your words revenue is 7 years away: "the ceo indicated some months ago in an interview that current pipeline may start generating revenue in 7 years  - best estimate could be in the 2030- 2035 range" Tencents 

CZO's plans in the October presntation are 1-3 and 3-5 years away as in the presentation. 

<< Previous
Bullboard Posts
Next >>